| 本文已被：浏览 2492次 下载 2110次 |
码上扫一扫！ |
| 丙型肝炎患者血清中丙型肝炎病毒交叉中和抗体的检测 |
| 吉瑾1,2,罗源2,陆伟3,朱勇喆2,戚中田2,王敦1*,赵平2* |
|
|
| (1. 西北农林科技大学植物资源与利用教育部重点实验室,杨凌 712100; 2. 第二军医大学基础部微生物学教研室,上海市医学生物防护重点实验室,上海 200433; 3. 第二军医大学基础部流行病学教研室,上海 200433) |
|
| 摘要: |
| [摘要]目的分析HCV感染者血清中是否存在交叉反应性中和抗体。 方法以分泌表达HCV包膜E2蛋白真核表达质粒转染的293T 细胞培养上清液中的HCV E2蛋白作为检测抗原,建立检测HCV E2抗体的ELISA方法,检测32份HCV抗体阳性的慢性丙肝患者血清,然后用免疫荧光分析血清与HCV全长包膜蛋白表达质粒转染的293T细胞的结合反应,再用5株HCV假病毒(HCVpp)及两株细胞培养产生的HCV(HCVcc)为模型分析血清的病毒中和活性。 结果32份HCV抗体阳性血清中,26份血清可检测出E2抗体,阳性率81.3%。其中HCV RNA阳性的12份血清均为E2抗体阳性,E2抗体水平与HCV RNA水平负相关。HCV E2抗体阳性血清对5株HCVpp以及两株HCVcc的感染性均有不同程度的中和作用,中和活性与E2抗体水平相平行。结论HCV感染可诱导保护性体液免疫应答,丙肝患者血清中存在交叉中和抗体,提示开发能诱导广泛交叉中和抗体的丙肝疫苗具有可行性。 |
| 关键词: 丙型肝炎病毒 丙型肝炎 中和抗体 |
| DOI：10.3724/SP.J.1008.2010.01184 |
| 投稿时间：2010-04-12修订日期：2010-11-05 |
| 基金项目:国家自然科学基金(30901348),上海市基础研究重点项目(08JC1405000)和上海市重点学科建设项目(B901). |
|
| Detection of hepatitis C virus cross-neutralization antibodies in sera of hepatitis C patients |
| JI Jin1,2, LUO Yuan2, LU Wei3 , ZHU Yong-zhe2, QI Zhong-tian2, WANG Dun1*, ZHAO Ping2* |
| (1. Key Laboratory of Plant Protection Resources & Pest Management of Ministry Education, Northwest A&F University, Yangling 712100, Shaanxi, China; 2. Department of Microbiology, Shanghai Key Laboratory of Medical Biodefense, College of Basic Medical Sciences, Second Military Medical University, Shanghai 200433, China; 3. Department of Epidemiology, College of Basic Medical Sciences, Second Military Medical University, Shanghai 200433, China) |
| Abstract: |
| [Abstract]ObjectiveTo investigate the presence of neutralization antibodies in the sera of hepatitis C patients. MethodsA eukaryotic expression plasmid encoding carboxyl terminal-truncated HCV envelope protein 2 (E2) was transfected into human 293T cells. ELISA method was established to examine the anti-E2 antibodies in the sera of 32 hepatitis C patients. The full-length envelope protein expression plasmid was transfected into 293T cells and the reactivity of transfectant with anti-E2 IgG positive sera was analyzed by immunofluorescence. Five strains of HCV pseudotype particle (HCVpp), including H77 (1a genotype), Con-1 (1b genotype), J4 (1b genotype), J6 (2a genotype), and UNK3a (3a genotype), and two strains of cell cultured HCV (HCVcc) were used to assay the neutralization activity of 12 anti-E2 positive serum samples. MethodsELISA results showed that 26 of 32 serum samples were anti-E2 IgG positive, with the positive rate being 81.3%. The 12 serum samples positive for HCV RNA were all anti-E2 IgG, and the virus load was negatively correlated with the anti-E2 antibody level. The anti-E2 positive sera could neutralize the infections of five strains of HCVpp and two strains of HCVcc to various extents, and the neutralization activity was consistent with the anti-E2 antibody level. MethodsIt is suggested that HCV infection can induce protective humoral immune response, and cross-neutralization antibodies against HCV are present in sera of hepatitis C patients, which indicates a feasibility for developing vaccines that can induce broadly-reactive neutralizing antibodies. |
| Key words: hepatitis C virus hepatitis C neutralization antibodies |
